

E. studydirector@aquila-bm.com
W. www.aquila-biomedical.com
Aquila Biomedical offers a boutique and quality service combining advanced disease models with unique tools, underpinned by world leading biomedical expertise.
Our initial offering - the Multiple Sclerosis (MS) suite, will help you to define both the efficacy and the mechanism of action of your test compound, whether it is aimed at inhibiting the autoimmune/inflammatory phase of MS and/or providing neuroprotection and remyelination.
Aquila BioMedical (MS) draws on a world-leading group of basic and clinical scientists with expertise in neuroscience, myelination and remyelination, regenerative medicine, neuroimmunology and inflammation biology to offer a unique range of in vitro and in vivo models.
Our study directors have long track records in immunomodulation and in glial cell biology. Our clients therefore benefit from unsurpassed consultancy when designing experiments and from the highest quality data analysis.